anti-B7-H3 CAR-T cell therapy (The Affiliated Hospital of Xuzhou Medical University)

N/A

Report date: 2025/06/11 11:06:44

Base Information

Drug Nameanti-B7-H3 CAR-T cell therapy (The Affiliated Hospital of Xuzhou Medical University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionCD276 antigen modulatorsImmunostimulantsT lymphocytes stimulants
TargetsCD276 antigen
Therapy Area/IndicationsPancreatic NeoplasmsLiver NeoplasmsGastrointestinal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesThe Affiliated Hospital Of Xuzhou Medical University
China Registration ClassN/A

Develop Information

Active CompaniesThe Affiliated Hospital Of Xuzhou Medical University
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsLiver NeoplasmsGastrointestinal Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A